Ancora Pharmaceuticals, Inc.

Medford, MA 02155

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $4.12MM
First Award Date 03/01/04
Most Recent Award Date 04/01/10

Key Personnel

Last Name Name Awards Contact
Plante Obadiah Plante 2
Christ William J Christ 3
Campbell A. Stewart Campbell 2

7 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 04/01/10 - 12/31/11

DESCRIPTION (provided by applicant): Plasmodium falciparum malaria afflicts up to 10% of the global population, resulting in over 600 million infections and two to three million deaths annually. Malaria-related fatalities arise predominantly from two clinically defined complications associated with severe disease: cerebral malaria (CM) and sever...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 04/06/09 - 03/31/10

DESCRIPTION (provided by applicant): Plasmodium falciparum malaria afflicts up to 10% of the global population, resulting in over 600 million infections and two to three million deaths annually. Malaria-related fatalities arise predominantly from two clinically defined complications associated with severe disease: cerebral malaria (CM) and sever...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-04-27
Budget: 09/01/07 - 02/28/10

DESCRIPTION (provided by applicant): Malarial disease represents one of the most pressing medical healthcare issues facing the world today. While limited drug treatment options exist, a vaccine solution is widely considered as one of the most effective therapeutic weapons to combat malaria. Despite years of research, though, malarial vaccine ini...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-04-27
Budget: 09/01/06 - 08/31/07

DESCRIPTION (provided by applicant): Malarial disease represents one of the most pressing medical healthcare issues facing the world today. While limited drug treatment options exist, a vaccine solution is widely considered as one of the most effective therapeutic weapons to combat malaria. Despite years of research, though, malarial vaccine ini...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-04-27
Budget: 09/01/05 - 08/31/06

DESCRIPTION (provided by applicant): Malarial disease represents one of the most pressing medical healthcare issues facing the world today. While limited drug treatment options exist, a vaccine solution is widely considered as one of the most effective therapeutic weapons to combat malaria. Despite years of research, though, malarial vaccine ini...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/15/04 - 10/14/05

DESCRIPTION (provided by applicant): Tuberculosis (TB) has plagued mankind for millennia. While several drugs and vaccine strategies have been developed to counter the TB, it remains a major infectious cause of morbidity and mortality worldwide. 1.Though the elucidation of the M. tuberculosis genome may yield novel drug targets, an efficacious...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/04 - 02/28/05

DESCRIPTION (provided by applicant): Plasmodium falciparum malaria infects 5-10% of the global population (400 million clinical cases) and kills two million people annually. As such it ranks along with HIV and TB as the most serious infectious disease of humanity. It is widely accepted that an efficacious vaccine is required to afford protectio...